24/7 Market News Snapshot 07 February, 2025 – Nutriband Inc. Common Stock (NASDAQ:NTRB)

February 7, 2025

DENVER, Colo., 07 February, 2025 (247marketnews.com) – (NASDAQ:NTRB) are discussed in this article.
Nutriband Inc. (NTRB) has recently experienced a remarkable surge in its stock performance, opening at $7.40 and soaring to $8.195, a rise of 22.86% from its previous close of $6.670. This uptrend is supported by substantial trading volume of 522.47K shares, reflecting heightened investor interest in the company’s innovative approaches within the pharmaceutical industry. The momentum suggests that traders should remain vigilant, as NTRB appears primed for further expansion, bolstered by excitement over its pioneering product offerings.

In parallel, Nutriband has made significant advancements in addressing the prevalent issues of drug misuse and abuse. The company announced it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its Aversa™ abuse deterrent technology. This development paves the way for a forthcoming U.S. patent, further solidifying Nutriband’s already robust intellectual property portfolio. The Aversa™ technology integrates specialized aversive agents into transdermal patches, effectively reducing the risks associated with the abuse and accidental exposure of drugs known for their high potential for misuse, particularly opioids and stimulants.

Central to Nutriband’s strategy is its effort to launch Aversa™ Fentanyl, which aspires to be the first abuse-deterrent fentanyl transdermal system of its kind on the market. This product is projected to capture a significant share of the pain management market, with peak annual U.S. sales anticipated to reach between $80 million and $200 million. Having garnered patents in 46 countries worldwide, Nutriband is strategically positioned to enhance its efforts in combating drug misuse on a global scale, underscoring its dedication to innovative solutions in the pharmaceutical landscape.

Related news for (NTRB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.